Bionano announces presentation of ogm utility across cancer genomics research applications at the american association for cancer research (aacr) annual meeting

San diego, april 13, 2023 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced its participation in the american association for cancer research (aacr) annual meeting 2023 with a broad range of content covering the utility of optical genome mapping (ogm) utility for cell bioprocessing quality control, solid tumor and hematological malignancy cancer research. aacr's annual meeting brings together industry, medical, and academic professionals to discuss advances in cancer science and medicine. the aacr conference will be held april 14-18, 2023, in orlando, florida.
BNGO Ratings Summary
BNGO Quant Ranking